CRMD – CorMedix Inc.

CorMedix Inc.

CRMD

$12.32

Name : CorMedix Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $835,600,320.00

EPSttm : 0.25

CorMedix Inc.

$12.32

1.44%

$0.18

Float Short %

13.02

Margin Of Safety %

Put/Call OI Ratio

0.29

EPS Next Q Diff

-0.08

EPS Last/This Y

1.31

EPS This/Next Y

0.7

Price

12.31

Target Price

Analyst Recom

1.29

Performance Q

82.79

Relative Volume

1.53

Beta

1.59

Ticker: CRMD

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-06-02	CRMD	12.72	0.20	0.09	46581
2025-06-03	CRMD	12.6	0.20	0.12	46902
2025-06-04	CRMD	12.38	0.20	0.50	47074
2025-06-05	CRMD	13.17	0.21	0.39	48542
2025-06-06	CRMD	13.96	0.23	0.07	48855
2025-06-09	CRMD	14.36	0.22	0.05	51092
2025-06-10	CRMD	14.88	0.21	0.11	53827
2025-06-11	CRMD	14.59	0.20	0.07	54534
2025-06-12	CRMD	14.85	0.20	0.01	55824
2025-06-13	CRMD	14.54	0.20	0.11	56650
2025-06-16	CRMD	14.34	0.20	0.05	56707
2025-06-17	CRMD	13.92	0.20	0.01	57036
2025-06-18	CRMD	13.56	0.19	0.30	59219
2025-06-20	CRMD	13.6	0.19	0.14	59533
2025-06-23	CRMD	16.57	0.25	0.16	22044
2025-06-24	CRMD	15.72	0.25	0.22	25075
2025-06-25	CRMD	14.97	0.25	0.28	25744
2025-06-26	CRMD	14.5	0.25	0.81	26253
2025-06-27	CRMD	12.49	0.27	0.34	27049
2025-06-30	CRMD	12.31	0.29	0.61	30619
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-06-02	CRMD	12.72	149.3	-	0.80
2025-06-03	CRMD	12.61	149.3	-	0.80
2025-06-04	CRMD	12.37	149.3	-	0.80
2025-06-05	CRMD	13.18	149.3	-	0.80
2025-06-06	CRMD	13.97	149.3	-	0.80
2025-06-09	CRMD	14.35	149.3	-	0.80
2025-06-10	CRMD	14.87	149.3	-	0.80
2025-06-11	CRMD	14.60	149.3	-	0.80
2025-06-12	CRMD	14.86	149.3	-	0.80
2025-06-13	CRMD	14.56	149.3	-	0.80
2025-06-16	CRMD	14.33	149.3	-	0.80
2025-06-17	CRMD	13.92	149.3	-	0.80
2025-06-18	CRMD	13.58	149.3	-	0.80
2025-06-20	CRMD	13.61	149.3	-	0.80
2025-06-23	CRMD	16.55	149.3	-	0.80
2025-06-24	CRMD	15.71	149.3	-	0.80
2025-06-25	CRMD	14.97	149.3	-	0.80
2025-06-26	CRMD	14.94	149.3	-	0.80
2025-06-27	CRMD	12.47	149.3	-	1.01
2025-06-30	CRMD	12.31	162.0	-	1.01
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-06-02	CRMD	0.08	2.70	12.81
2025-06-03	CRMD	0.08	2.70	12.81
2025-06-04	CRMD	0.08	2.70	12.81
2025-06-05	CRMD	0.08	2.70	12.81
2025-06-06	CRMD	0.08	2.70	12.81
2025-06-09	CRMD	0.08	2.70	12.81
2025-06-10	CRMD	0.08	2.70	12.81
2025-06-11	CRMD	0.08	2.70	12.94
2025-06-12	CRMD	0.08	2.70	12.94
2025-06-13	CRMD	0.08	2.70	12.94
2025-06-16	CRMD	0.00	2.56	12.94
2025-06-18	CRMD	0.00	2.56	12.94
2025-06-20	CRMD	0.00	2.56	12.94
2025-06-23	CRMD	0.00	2.56	12.94
2025-06-24	CRMD	0.00	2.56	12.94
2025-06-25	CRMD	0.00	2.56	12.94
2025-06-26	CRMD	0.00	2.56	13.02
2025-06-27	CRMD	0.00	2.56	13.02
2025-06-30	CRMD	0.00	3.72	13.02
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.3

Avg. EPS Est. Current Quarter

0.15

Avg. EPS Est. Next Quarter

0.22

Insider Transactions

Institutional Transactions

3.72

Beta

1.59

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

34.5

Max Drawdown 5-Year %

-84.5

Target Price

P/E

54.66

Forward P/E

7.29

PEG

P/S

10.12

P/B

7.26

P/Free Cash Flow

EPS

0.23

Average EPS Est. Cur. Y

1.01

EPS Next Y. (Est.)

1.71

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

20.81

Relative Volume

1.53

Return on Equity vs Sector %

-8.9

Return on Equity vs Industry %

10.2

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.21

EBIT Estimation

CorMedix Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 64

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

stock quote shares CRMD – CorMedix Inc. Stock Price stock today

news today CRMD – CorMedix Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CRMD – CorMedix Inc. yahoo finance google finance

stock history CRMD – CorMedix Inc. invest stock market

stock prices CRMD premarket after hours

ticker CRMD fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

CRMD – CorMedix Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: CRMD

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y